METHOD FOR PROVIDING INFORMATION FOR EVALUATING PROGNOSIS OF LUNG CANCER PATIENT, METHOD FOR PREDICTING PROGNOSIS OF LUNG CANCER PATIENT, INTERNAL STANDARD, ANTIBODY, DEVICE FOR PREDICTING PROGNOSIS OF LUNG CANCER PATIENT, PROGRAM FOR PROGNOSIS PREDICTION DEVICE, AND RECORDING MEDIUM

摘要

Provided is a method for predicting the possibility of the relapse of lung cancer even at an early stage, regardless of the types of the lung cancer. The possibility of the relapse of lung cancer can be predicted even at an early stage regardless of the types of the lung cancer by a method for providing information for predicting the prognosis of a lung cancer patient, wherein the method comprises determining the expressed amounts of at least four kinds of proteins, i.e., g1027 (Accession No. sp|P12814|ACTN1_HUMAN), g1237 (Accession No. sp|P22392-2|NDKB_HUMAN), g1463 (Accession No. sp|P35221|CTNA1_HUMAN) and g1821 (Accession No. sp|P51690|ARSE_HUMAN), in a sample from the lung cancer patient.